AccelBio

AccelBio is a private non-profit association, recognized as a Collaborative Laboratory (CoLAB) by FCT (Portuguese R&D funding agency).
AccelBio mission is to facilitate and accelerate translation, commercialization, and global dissemination of cutting-edge biomedical discoveries and innovations originating from research and development centres based in Portugal.
AccelBio leverages and complements the combined existing drug discovery capacities of all associate members ranging from target validation to preclinical studies.

Mission & Goals

•  
• - R&D agenda in key emerging technology platforms: Develop unique platforms enabling multiple drug discovery programs
• - Acceleration of drug discovery projects: Identify and translate drug targets into drug discovery programs and new drugs
• - Train the next generation of Biotech Business Leaders: High scientific knowledge merged with a strong preparation in entrepreneurship and business

Research

Based on advanced technological platforms and an integrated team of wet lab scientists, translational researchers, medicinal chemists, and bioinformaticians, AccelBio provides customized support to drive biomedical projects towards successful translation. Our expertise enables risk mitigation and acceleration across the drug discovery pipeline, including critical stages such as target validation, hit identification, lead optimization, and preclinical development.

Consulting

Creating a translational roadmap from research to market helps reduce risk and improves your project's chances of success. Our consulting services include support to the design of Target Drug Profiles, Development and Business Plans or performing Market Analysis for your asset/project. We also support you in defining industry-based best practices, leading to high-quality drug candidates.